252 related articles for article (PubMed ID: 23377526)
1. A new treatment regimen for rosacea: onabotulinumtoxinA.
Dayan SH; Pritzker RN; Arkins JP
J Drugs Dermatol; 2012 Dec; 11(12):e76-9. PubMed ID: 23377526
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.
Park KY; Hyun MY; Jeong SY; Kim BJ; Kim MN; Hong CK
Dermatology; 2015; 230(4):299-301. PubMed ID: 25765295
[TBL] [Abstract][Full Text] [Related]
3. Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing.
Al-Niaimi F; Glagoleva E; Araviiskaia E
Dermatol Ther; 2020 Nov; 33(6):e13976. PubMed ID: 32633449
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea.
Hsu CC; Lee JY
Arch Dermatol; 2011 Nov; 147(11):1258-60. PubMed ID: 21768447
[No Abstract] [Full Text] [Related]
5. The toxic edge-A novel treatment for refractory erythema and flushing of rosacea.
Friedman O; Koren A; Niv R; Mehrabi JN; Artzi O
Lasers Surg Med; 2019 Apr; 51(4):325-331. PubMed ID: 30311683
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline.
Shanler SD; Ondo AL
Arch Dermatol; 2007 Nov; 143(11):1369-71. PubMed ID: 18025359
[No Abstract] [Full Text] [Related]
7. Botulinum toxin blocks mast cells and prevents rosacea like inflammation.
Choi JE; Werbel T; Wang Z; Wu CC; Yaksh TL; Di Nardo A
J Dermatol Sci; 2019 Jan; 93(1):58-64. PubMed ID: 30658871
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
[TBL] [Abstract][Full Text] [Related]
9. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
10. 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings.
Schmidt JB; Gebhart W; Raff M; Spona J
Acta Derm Venereol; 1984; 64(1):15-21. PubMed ID: 6203275
[TBL] [Abstract][Full Text] [Related]
11. Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.
Tong LX; Moore AY
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):567-77. PubMed ID: 25091290
[TBL] [Abstract][Full Text] [Related]
12. Epigastric rosacea.
Wilkin JK
Arch Dermatol; 1980 May; 116(5):584. PubMed ID: 6445709
[TBL] [Abstract][Full Text] [Related]
13. Retinaldehyde alleviates rosacea.
Vienne MP; Ochando N; Borrel MT; Gall Y; Lauze C; Dupuy P
Dermatology; 1999; 199 Suppl 1():53-6. PubMed ID: 10473962
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea.
Tong Y; Luo W; Gao Y; Liu L; Tang Q; Wa Q
Dermatol Ther; 2022 May; 35(5):e15395. PubMed ID: 35187781
[TBL] [Abstract][Full Text] [Related]
15. A Pilot, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of IncobotulinumtoxinA Injections in the Treatment of Rosacea.
Dayan SH; Ashourian N; Cho K
J Drugs Dermatol; 2017 Jun; 16(6):549-554. PubMed ID: 28686772
[TBL] [Abstract][Full Text] [Related]
16. Treating rosacea with botulism toxin: Protocol for a systematic review and meta-analysis.
He G; Yang Q; Wu J; Huang Y; Zheng H; Cheng H
J Cosmet Dermatol; 2024 Jan; 23(1):44-61. PubMed ID: 37605478
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea.
Katz B; Patel V
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):6-8. PubMed ID: 16485874
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of a novel topical composition on persistent redness observed in patients who had been successfully treated with topical or oral therapy for papulopustular rosacea.
Baldwin H; Berson D; Vitale M; Yatskayer M; Chen N; Oresajo C
J Drugs Dermatol; 2014 Mar; 13(3):326-31. PubMed ID: 24595579
[TBL] [Abstract][Full Text] [Related]
19. Neurogenic Rosacea Treatment: A Literature Review.
Ivanic MG; Oulee A; Norden A; Javadi SS; Gold MH; Wu JJ
J Drugs Dermatol; 2023 Jun; 22(6):566-575. PubMed ID: 37276164
[TBL] [Abstract][Full Text] [Related]
20. Facial flushing and erythema of rosacea improved by carvedilol.
Seo BH; Kim DH; Suh HS; Choi YS
Dermatol Ther; 2020 Nov; 33(6):e14520. PubMed ID: 33174351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
